Public Inspection: CMS: Medicare and Medicaid Programs: Calendar Year 2025 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; etc.

Federal Register

Jul 11, 2024

Pre-publication notice of a proposed rule from the Centers for Medicare & Medicaid Services (CMS) addressing: 1) changes to the Physician Fee Schedule and Medicare Part B payment policies; 2) policies for the Medicare Prescription Drug Inflation Rebate program under the Inflation Reduction Act of 2022; 3) updates to the Medicare Diabetes Prevention Program expanded model; payment for dental services inextricably linked to specific covered medical services; 4) updates to drugs and biological products paid under Part B including immunosuppressive drugs and clotting factors; 5) Medicare Shared Savings Program requirements; 6) updates to the Quality Payment Program; 7) Medicare coverage of opioid use disorder services furnished by opioid treatment programs; 8) updates to policies for Rural Health Clinics (RHCs) and Federally Qualified Health Centers (FQHCs); 9) electronic prescribing for controlled substances for a covered Part D drug under a prescription drug plan or an MA-PD plan; 10) updates to the Ambulance Fee Schedule regulations; 11) updates to Clinical Laboratory Fee Schedule regulations; 12) updates to the diabetes payment structure and COVID-19 public health emergency (PHE) flexibilities; 13) expansion of colorectal cancer screening and Hepatitis B vaccine coverage and payment; 14) establishing payment for drugs covered as additional preventive services; and 15) Medicare Parts A and B Overpayment Provisions of the Affordable Care Act. Comments are due by September 9, 2024.

Diabetes · Emergency medical services · Federally Qualified Health Centers · Healthcare quality · Illicit drug use · Legislation and regulations · Medicare · Oral health · Pharmacy and prescription drugs · Prescription drug misuse · Reimbursement and payment models · Rural Health Clinics